Dear colleagues,
It is a local news, but of general interest, I think. Russian court
first time permitted the forced license for the patented drug -
lenalidomide - for the Russian company. Russia has the legislation
directed to keep costs for generics lower, but there are plenty of
tricks how to rise them. Also Russian doctors tend not to believe that
Russian generics are good enough.
VVV
--
\/.\/.\/.
Vasiliy V. Vlassov, MD
Professor, National Research University Higher School of Economics
e-mail: vlassov[a t]cochrane.ru
Web page https://www.hse.ru/en/org/persons/14527416
snail mail: P.O.Box 13 Moscow 109451 Russia
Phone Russia +7(965)2511021
########################################################################
To unsubscribe from the EVIDENCE-BASED-HEALTH list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=EVIDENCE-BASED-HEALTH&A=1
|